Solid Tumour

Oncology

20 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(8)

Phase 2(2)

Drug	Company
Cetrelimab	ENANTA PHARMACEUTICALS INC (ENTA)
Tislelizumab Injection	Merus N.V. (MRUS)

Phase 1(5)

Drug	Company
[111in]-fpi-1547	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection multi-dose	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection single-dose	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1175 infusion	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1434	Fusion Pharmaceuticals Inc. (FUSN)

Phase 1/Phase 2(1)

Drug	Company
PYX-201	Pyxis Oncology, Inc. (PYXS)

Phase 2/Phase 3(2)

Drug	Company
azd1775	ASTRAZENECA PLC (AZN)
AZD9592	ASTRAZENECA PLC (AZN)

Phase 4(2)

Drug	Company
bms-986517	BRISTOL MYERS SQUIBB CO (BMY)
LBL-024 for Injection	Merus N.V. (MRUS)

BioSniper tracks 20 drugs in development for Solid Tumour across 6 companies.

There are 1 clinical trial targeting Solid Tumour tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.